NuVasive Launches AttraX Scaffold Biologic in the US

NuVasive commenced U.S. launch of AttraX® Scaffold absorbent ceramic-collagen bone graft.

The surface of AttraX has been validated in preclinical testing to drive increased bone formation and faster fusion vs. traditional ceramic bone grafts, reportedly supporting differentiation of mesenchymal stem cells into bone-forming osteoblasts without...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us